

17 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/17/3257691/0/en/Beyond-Cancer-Reports-Early-Clinical-Activity-and-Favorable-Safety-Profile-with-Interim-Data-from-Phase-1-UNO-Trial.html

11 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/11/3253622/0/en/Beyond-Air-to-Participate-in-the-38th-Annual-Roth-Conference-in-March.html

10 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/10/3252660/0/en/Beyond-Air-Announces-Termination-of-Agreement-to-Sell-Its-NeuroNOS-Subsidiary-to-XTL-Biopharmaceuticals-Ltd.html

04 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/04/3232002/0/en/Beyond-Cancer-Abstract-Featuring-Phase-1-Data-on-Intratumoral-Ultra-High-Concentration-Nitric-Oxide-UNO-in-Solid-Tumor-Metastases-to-be-Presented-at-the-AACR-Annual-Meeting-2026.html

27 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/27/3227075/0/en/Beyond-Air-to-Participate-in-Two-Upcoming-Healthcare-Investor-Conferences.html

26 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/26/3225973/0/en/Beyond-Air-Schedules-Third-Fiscal-Quarter-2026-Financial-Results-Conference-Call-and-Webcast.html